CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Market share analysis, 2020
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Increase in incidences of musculoskeletal conditions
3.4.1.2.Technological advancements in medical devices leading to a shift from autograft to allograft
3.4.1.3.Development of biocompatible synthetic bone grafts
3.4.1.4.Obesity and diabetes to increase the risk of degenerative joint diseases

3.4.2.Restraints

3.4.2.1.High cost of surgeries
3.4.2.2.Ethical issues related with bone grafting procedures

3.4.3.Opportunities

3.4.3.1.Emerging markets to offer lucrative growth opportunities

3.5.Government Regulations

3.5.1.FDA
3.5.2.Health Canada
3.5.3.CE Mark
3.5.4.Ministry of Health, Labor and Welfare (MHLW)
3.5.5.Therapeutic Goods Administration (TGA)

3.6.Reimbursement Scenario

3.6.1.U.S.
3.6.2.Europe
3.6.3.Asia-Pacific
3.6.4.LAMEA

3.7.COVID-19 Impact analysis on the market

CHAPTER 4:BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Allografts

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by type
4.2.3.Market size and forecast, by region
4.2.4.Market analysis, by country
4.2.5.Machined Allografts

4.2.5.1.Market size and forecast

4.2.6.Demineralized Bone Matrix (DBM)
4.2.6.1.Market size and forecast

4.3.Bone Graft Substitutes

4.3.1.Key market trends growth factors and opportunities
4.3.2.Market size and forecast
4.3.3.Market size and forecast, by region
4.3.4.Market analysis, by country
4.3.5.Bone Morphogenic Proteins (BMP)

4.3.5.1.Market size and forecast

4.3.6.Synthetic Bone Grafts

4.3.6.1.Market size and forecast

4.4.Cell-based Matrices (CBM)

4.4.1.Key market trends, growth factors and opportunities
4.4.1.1.Cell-based matrices-major products
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country

CHAPTER 5:BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Spinal Fusion

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Trauma

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

5.4.Craniomaxillofacial Surgery

5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country

5.5.Joint Reconstruction

5.5.1.Market size and forecast
5.5.2.Market analysis, by country

5.6.Dental Bone Grafting

5.6.1.Market size and forecast
5.6.2.Market analysis, by country

CHAPTER 6:BONE GRAFTS & SUBSTITUTES MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast

6.2.North America

6.2.1.Key market trends, growth factors and opportunities
6.2.2.Market size and forecast, by country

6.2.2.1.U.S.

6.2.2.1.1.U.S. Bone grafts & substitutes market by type
6.2.2.1.2.U.S. Bone grafts & substitutes market by application

6.2.2.2.Canada

6.2.2.2.1.Canada Bone grafts & substitutes market by type
6.2.2.2.2.Canada Bone grafts & substitutes market by application

6.2.2.3.Mexico

6.2.2.3.1.Mexico Bone grafts & substitutes market by type
6.2.2.3.2.Mexico Bone grafts & substitutes market by application

6.2.3.Market size and forecast, by type
6.2.4.Market size and forecast, by application

6.3.Europe

6.3.1.Key market trends, growth factors and opportunities
6.3.2.Market size and forecast, by country

6.3.2.1.Germany

6.3.2.1.1.Germany Bone grafts & substitutes market by type
6.3.2.1.2.Germany Bone grafts & substitutes market by application

6.3.2.2.France

6.3.2.2.1.France Bone grafts & substitutes market by type
6.3.2.2.2.France Bone grafts & substitutes market by application

6.3.2.3.Italy

6.3.2.3.1.Italy Bone grafts & substitutes market by type
6.3.2.3.2.Italy Bone grafts & substitutes market by application

6.3.2.4.Spain

6.3.2.4.1.Spain Bone grafts & substitutes market by type
6.3.2.4.2.Spain Bone grafts & substitutes market by application

6.3.2.5.UK

6.3.2.5.1.UK Bone grafts & substitutes market by type
6.3.2.5.2.UK Bone grafts & substitutes market by application

6.3.2.6.Rest of Europe

6.3.2.6.1.Rest of Europe Bone grafts & substitutes market by type
6.3.2.6.2.Rest of Europe Bone grafts & substitutes market by application

6.3.3.Market size and forecast, by type
6.3.4.Market size and forecast, by application

6.4.Asia-Pacific

6.4.1.Key market trends, growth factors and opportunities
6.4.2.Market size and forecast, by country

6.4.2.1.Japan

6.4.2.1.1.Japan Bone grafts & substitutes market, by type
6.4.2.1.2.Japan Bone grafts & substitutes market, by application

6.4.2.2.China

6.4.2.2.1.China Bone grafts & substitutes market, by type
6.4.2.2.2.China Bone grafts & substitutes market, by application

6.4.2.3.India

6.4.2.3.1.India Bone grafts & substitutes market, by type
6.4.2.3.2.India Bone grafts & substitutes market, by application

6.4.2.4.Australia

6.4.2.4.1.Australia Bone grafts & substitutes market, by type
6.4.2.4.2.Australia Bone grafts & substitutes market, by application

6.4.2.5.South Korea

6.4.2.5.1.South Korea Bone grafts & substitutes market, by type
6.4.2.5.2.South Korea Bone grafts & substitutes market, by application

6.4.2.6.Rest of Asia-Pacific

6.4.2.6.1.Rest of Asia-Pacific Bone grafts & substitutes market, by type
6.4.2.6.2.Rest of Asia-Pacific Bone grafts & substitutes market, by application

6.4.3.Asia-Pacific Bone grafts &substitutes market, by type
6.4.4.Asia-Pacific Bone grafts & substitutes market, by application

6.5.LAMEA

6.5.1.Key market trends, growth factors and opportunities
6.5.2.Market size and forecast, by country

6.5.2.1.Brazil

6.5.2.1.1.Brazil bone grafts & substitutes market, by type
6.5.2.1.2.Brazil bone grafts & substitutes market, by application

6.5.2.2.Israel

6.5.2.2.1.Israel bone grafts & substitutes market, by type
6.5.2.2.2.Israel bone grafts & substitutes market, by application

6.5.2.3.Saudi Arabia

6.5.2.3.1.Saudi Arabia bone grafts & substitutes market, by type
6.5.2.3.2.Saudi Arabia bone grafts & substitutes market, by application

6.5.2.4.South Africa

6.5.2.4.1.South Africa bone grafts & substitutes market, by type
6.5.2.4.2.South Africa bone grafts & substitutes market, by application

6.5.2.5.Rest of LAMEA

6.5.2.5.1.Rest of LAMEA bone grafts & substitutes market, by type
6.5.2.5.2.Rest of LAMEA bone grafts & substitutes market, by application

6.5.3.Market size and forecast, by type
6.5.4.Market size and forecast, by application

CHAPTER 7:COMPANY PROFILES

7.1.ARTHREX, INC.

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product Portfolio

7.2.BAXTER INTERNATIONAL INC.

7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product Portfolio
7.2.5.Business performance
7.2.6.Key strategic moves and developments

7.3.INTEGRA LIFESCIENCES HOLDINGS CORPORATION

7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance

7.4.JOHNSON & JOHNSON (DEPUY SYNTHES)

7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product Portfolio
7.4.5.Business performance

7.5.MEDTRONIC PLC

7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments

7.6.MUSCULOSKELETAL TRANSPLANT FOUNDATION

7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product Portfolio

7.7.NUVASIVE, INC.

7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product Portfolio
7.7.5.Business performance
7.7.6.Key strategic moves and developments

7.8.STRYKER CORPORATION

7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Business performance
7.8.6.Key strategic moves and developments

7.9.XTANT MEDICAL HOLDINGS, INC.

7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product Portfolio
7.9.5.Business performance

7.10.ZIMMER BIOMET HOLDINGS, INC.,

7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance